Page 3 - ஞாயிற்றுக்கிழமை வாஷிங்டன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BusinessWorld April 28, 2021 | 12:07 am WASHINGTON — An agreement between the United States and three of its closest Indo-Pacific partners to produce up to a billion coronavirus vaccine doses in India by the end of 2022 to supply other Asian countries is “still on track,” senior US officials said on Monday, despite a surge of coronavirus disease 2019 (COVID-19) in India. “It’s moving forward expeditiously,” a senior administration official told reporters in a briefing call, referring to the agreement last month between the leaders of the United States, India, Japan and Australia, a grouping known as the Quad. A fact sheet issued after the countries held a virtual summit in March said the United States, through its International Development Finance Corp., would work to finance Indian drugmaker Biological E Ltd. to produce at least 1 billion COVID-19 vaccine doses by the end of 2022.

United statesWhite houseDistrict of columbiaJosephr biden jrE ltdInternational development finance corpAstrazeneca plcSoutheast asianSunday washingtonஒன்றுபட்டது மாநிலங்களில்வெள்ளை வீடுமாவட்டம் ஆஃப் கொலம்பியாஏ லிமிடெட்சர்வதேச வளர்ச்சி நிதி கார்ப்தென்கிழக்கு ஆசியஞாயிற்றுக்கிழமை வாஷிங்டன்